1219
福壽
-0.05 (-0.44%)11.20189成交張數–本益比0.96股價淨值比4.46%殖利率2026-09-15資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該科目 ÷ 營業收入
營業收入202514,382年增 +0.4%
毛利率20258.5%最新一期
營業利益率20250.0%最新一期
每股盈餘20250.45年增 -15.1%
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 銷貨收入 | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 銷貨收入淨額 | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 營業收入合計 | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 營業成本合計 | 91.1% | 91.7% | 93.1% | 91.9% | 89.0% | 90.8% | 91.4% | 90.9% | 90.7% | 91.4% | |
| 生物資產當期公允價值減出售成本之變動利益(損失) | – | – | -0.1% | -0.0% | 0.1% | -0.0% | -0.0% | 0.0% | 0.1% | -0.1% | |
| 營業毛利（毛損） | 8.9% | 8.3% | 6.7% | 8.1% | 11.0% | 9.2% | 8.6% | 9.2% | 9.4% | 8.5% | |
| 未實現銷貨（損）益 | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | |
| 已實現銷貨（損）益 | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | |
| 營業毛利（毛損）淨額 | 8.9% | 8.3% | 6.7% | 8.1% | 11.0% | 9.2% | 8.6% | 9.2% | 9.4% | 8.5% | |
| 推銷費用 | 5.2% | 5.2% | 5.0% | 5.2% | 5.3% | 4.8% | 4.5% | 4.5% | 5.6% | 5.5% | |
| 管理費用 | 2.7% | 2.7% | 2.2% | 2.3% | 2.7% | 2.2% | 1.9% | 2.1% | 2.7% | 2.6% | |
| 研究發展費用 | 0.3% | 0.3% | 0.4% | 0.3% | 0.3% | 0.2% | 0.3% | 0.3% | 0.3% | 0.3% | |
| 預期信用減損損失（利益） | – | – | -0.1% | 0.0% | 0.1% | -0.1% | 0.0% | 0.0% | -0.0% | 0.1% | |
| 營業費用合計 | 8.3% | 8.2% | 7.5% | 7.9% | 8.3% | 7.2% | 6.7% | 7.0% | 8.6% | 8.5% | |
| 營業利益（損失） | 0.7% | 0.1% | -0.7% | 0.3% | 2.7% | 2.0% | 1.8% | 2.2% | 0.8% | 0.0% | |
| 利息收入 | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | |
| 其他收入 | 0.2% | 0.2% | 0.1% | 0.2% | 0.4% | 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | |
| 其他利益及損失淨額 | 0.1% | 0.4% | -0.0% | 1.1% | 2.3% | 0.0% | 0.1% | 0.1% | 0.1% | -0.1% | |
| 財務成本淨額 | 0.3% | 0.4% | 0.4% | 0.5% | 0.3% | 0.3% | 0.3% | 0.5% | 0.6% | 0.6% | |
| 採用權益法認列之關聯企業及合資損益之份額淨額 | 0.2% | 0.3% | 0.3% | 0.3% | 0.4% | 0.4% | 0.4% | 0.4% | 0.5% | 0.5% | |
| 營業外收入及支出合計 | 0.2% | 0.4% | -0.0% | 1.2% | 2.8% | 0.3% | 0.4% | 0.2% | 0.2% | 0.1% | |
| 稅前淨利（淨損） | 0.9% | 0.5% | -0.7% | 1.4% | 5.5% | 2.4% | 2.2% | 2.4% | 1.0% | 0.2% | |
| 所得稅費用（利益）合計 | 0.3% | 0.0% | 0.1% | 0.3% | 0.9% | 0.5% | 0.4% | 0.4% | 0.2% | 0.2% | |
| 繼續營業單位本期淨利（淨損） | 0.5% | 0.5% | -0.8% | 1.2% | 4.6% | 1.9% | 1.8% | 2.0% | 0.7% | -0.0% | |
| 本期淨利（淨損） | 0.5% | 0.5% | -0.8% | 1.2% | 4.6% | 1.9% | 1.8% | 2.0% | 0.7% | -0.0% | |
| 確定福利計畫之再衡量數 | -0.2% | 0.1% | -0.0% | 0.0% | -0.0% | -0.0% | 0.0% | -0.0% | 0.0% | -0.0% | |
| 與不重分類之項目相關之所得稅 | -0.0% | 0.0% | -0.0% | 0.0% | -0.0% | -0.0% | 0.0% | -0.0% | 0.0% | -0.0% | |
| 不重分類至損益之項目： | – | – | – | 0.0% | 0.0% | -0.0% | 0.0% | 0.0% | 0.0% | -0.0% | |
| 國外營運機構財務報表換算之兌換差額 | -0.0% | -0.0% | -0.0% | -0.0% | 0.0% | -0.0% | 0.0% | -0.0% | 0.0% | 0.0% | |
| 與可能重分類之項目相關之所得稅 | -0.0% | -0.0% | -0.0% | -0.0% | 0.0% | -0.0% | 0.0% | -0.0% | 0.0% | 0.0% | |
| 後續可能重分類至損益之項目： | – | – | – | -0.0% | 0.0% | -0.0% | 0.0% | -0.0% | 0.0% | 0.0% | |
| 其他綜合損益（淨額） | -0.2% | 0.0% | -0.0% | -0.0% | 0.0% | -0.0% | 0.0% | -0.0% | 0.0% | -0.0% | |
| 本期綜合損益總額 | 0.3% | 0.5% | -0.8% | 1.1% | 4.6% | 1.9% | 1.8% | 2.0% | 0.8% | -0.0% | |
| 母公司業主（淨利∕損） | 1.4% | 1.3% | -0.1% | 1.7% | 5.0% | 2.2% | 1.9% | 1.9% | 1.3% | 1.1% | |
| 非控制權益（淨利∕損） | -0.9% | -0.8% | -0.7% | -0.5% | -0.4% | -0.3% | -0.1% | 0.1% | -0.5% | -1.1% | |
| 母公司業主（綜合損益） | 1.2% | 1.3% | -0.1% | 1.6% | 5.0% | 2.2% | 1.9% | 1.9% | 1.3% | 1.1% | |
| 非控制權益（綜合損益） | -0.9% | -0.8% | -0.7% | -0.5% | -0.4% | -0.3% | -0.1% | 0.1% | -0.5% | -1.1% | |
| 基本每股盈餘 | 0.0% | 0.0% | -0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | |
| 採用權益法認列之關聯企業及合資之其他綜合損益之份額-不重分類至損益之項目 | -0.0% | -0.0% | -0.0% | -0.0% | 0.0% | -0.0% | 0.0% | 0.0% | 0.0% | – | |
| 銷貨成本 | – | – | 93.1% | 91.9% | – | – | – | – | – | – |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。